Cross-Border Pollination? J&J China R&D Center Bonds With Indian Unit For Local Innovation
This article was originally published in PharmAsia News
Executive Summary
CHENNAI, India - Having established a device R&D innovation center in Suzhou, China, in July, Johnson & Johnson Medical Ltd. and DePuy, the $5 billion orthopaedics, spinal care and neurosciences franchise of Johnson & Johnson Company, have started working closely with their Indian counterparts in Mumbai to obtain local insights needed to develop products appropriate for the Asian marketplace
You may also be interested in...
Emerging Views On Emerging Markets: Cowen Group Healthcare Conference
PharmAsia News takes a closer look at presentations referencing emerging markets by Abbott, Amgen, Cardinal Health, Charles River Labs and J&J.
Emerging Views On Emerging Markets: Cowen Group Healthcare Conference
PharmAsia News takes a closer look at presentations referencing emerging markets by Abbott, Amgen, Cardinal Health, Charles River Labs and J&J.
Emerging Views On Emerging Markets: Leerink Swann Global Healthcare Conference
PharmAsia News takes a closer look at presentations by Alexion, Amgen, J&J, Merck and Novartis during one of the industry’s major investor conferences.